Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults-Reference-Cited by-同舟云学术

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults

Published:2023-06-21 Issue:6 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chakupurakal Geothy¹²,Freudenberger Paul³,Skoetz Nicole⁴,Ahr Hans⁵,Theurich Sebastian⁶⁷⁸

Affiliation:

1. Praxis for Haematology and Oncology; Koblenz Germany

2. Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine at the University of Cologne; Cologne Germany

3. CGS Clinical Guideline Services GmbH; Kiel Germany

4. Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

5. Rheinland Klinikum; Dormagen Germany

6. Department of Medicine III; University Hospital LMU, Ludwig-Maximilians-Universität München; Munich Germany

7. Cancer and Immunometabolism Research Group; Gene Center LMU; Munich Germany

8. German Cancer Consortium (DKTK), Munich Site ; German Cancer Research Center; Heidelberg Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference116 articles.

1. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation;Bacigalupo;Biology of Blood and Marrow Transplantation,2006

2. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO);Bacigalupo;Blood,2001

3. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation;Bacigalupo;Biology of Blood and Marrow Transplantation,2006

4. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO);Bacigalupo;Blood,2001

5. Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: A multicenter, open-label, randomized controlled study;Chang;Journal of Clinical Oncology,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of interleukin-2 in graft-versus-host disease pathogenesis, prevention and therapy;Cytokine;2024-11

2. In adults undergoing allogeneic stem cell or bone marrow transplantation, do polyclonal antithymocyte globulins (ATGs) prevent graft-versus-host disease (GVHD)?;Cochrane Clinical Answers;2024-06-28

3. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06